Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor

Anticancer Research

Volumn 33, Issue 7, 2013, Pages 2941-2948

  Gotanda, Yukito ^a   Akagi, Yoshito ^a   Kawahara, Akihiko ^a   Kinugasa, Tetsushi ^a   Yoshida, Takefumi ^a   Ryu, Yasuhiko ^a   Shiratsuchi, Ichitaro ^a   Kage, Masayoshi ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; MCT4; Tumor growth; VEGF

Indexed keywords

MONOCARBOXYLATE TRANSPORTER 4; VASCULOTROPIN;

ADULT; AGED; CANCER GROWTH; CANCER SURGERY; COLORECTAL CANCER; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR VOLUME;

COLORECTAL CANCER; MCT4; TUMOR GROWTH; VEGF;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883267181     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Garcia CK, Goldstein JL, Pathak RK, Anderson RG and Brown MS: Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: Implications for the Cori cycle. Cell 76: 865-873, 1994.
2. Halestrap AP and Price NT: The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem J 343(Pt 2): 281-299, 1999.
3. Koukourakis MI, Giatromanolaki A, Harris AL and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res 66: 632-637, 2006.
4. Gerlinger M, Santos CR, Spencer-Dene B, Martinez P, Endesfelder D, Burrell RA, Vetter M, Jiang M and Saunders RE, Kelly G, Dykema K, Rioux-Leclercq N, Stamp G, Patard JJ, Larkin J, Howell M and Swanton C: Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. J Pathol 227: 146-156, 2012.
5. Vaupel P, Kallinowski F and Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49: 6449-6465, 1989.
6. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P and Vaupel P: Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49: 3759-3764, 1989.
7. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, Baessler KH, Wagner K, Mueller-Klieser W and Walenta S: Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 48: 7264-7272, 1988.
8. Halestrap AP: The monocarboxylate transporter family - structure and functional characterization. IUBMB Life 64: 1-9, 2012.
9. Vegran F, Boidot R, Michiels C, Sonveaux P and Feron O: Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71: 2550-2560, 2011.
10. Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakami T, Yoshida T, Nomoto M and Kohno K: Cellular pH regulators: Potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 29: 541-549, 2003.
11. Ullah MS, Davies AJ and Halestrap AP: The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-α-dependent mechanism. J Biol Chem 281: 9030-9037, 2006.
12. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F and Baltazar F: Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 452: 139-146, 2008.
13. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F and Baltazar F: Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010: 427694, 2010.
14. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N and Drewes LR: Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 12: 761-765, 2001.
15. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S and Kohno K: Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102: 1007-1013, 2011.
16. Pertega-Gomes N, Vizcaino JR, Miranda-Goncalves V, Pinheiro C, Silva J, Pereira H, Monteiro P, Henrique RM, Reis RM, Lopes C and Baltazar F: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer 11: 312, 2011.
17. Pinheiro C, Longatto-Filho A, Simoes K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F and Baltazar F: The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur J Cancer 45: 2418-2424, 2009.
18. Gallagher SM, Castorino JJ, Wang D and Philp NJ: Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 67: 4182-4189, 2007.
19. Harada Y, Ogata Y and Shirouzu K: Expression of vascular endothelial growth factor and its receptor KDR (kinase domaincontaining receptor)/Flk1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. Int J Clin Oncol 6: 221-228, 2001.
20. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
21. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
22. Cao D, Hou M, Guan YS, Jiang M, Yang Y and Gou HF: Expression of HIF-1α and VEGF in colorectal cancer: Association with clinical outcomes and prognostic implications. BMC Cancer 9: 432, 2009.
23. Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A and Kombouras C: Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 147: 99-107, 2008.
24. Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, Syrjanen K, Collan Y and Pyrhonen S: VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res 28: 3865-3870, 2008.
25. Kondo Y, Arii S, Furutani M, Isigami S, Mori A, Onodera H, Chiba T and Imamura M: Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma. Cancer 88: 1820-1827, 2000.
26. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
27. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
28. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989.
29. Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ and Reed MW: The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut 56: 1426-1432, 2007.